Dr. Hiutung Chu's lab at UC San Diego focuses on understanding how the gut microbiota, particularly commensal bacteria like Bacteroides fragilis, adapt in response to inflammation caused by conditions such as inflammatory bowel disease (IBD). The research aims to uncover how these bacterial adaptations influence immune responses, which could lead to new therapies for IBD. By exploring the genetic and metabolic changes in these bacteria, the lab seeks to develop strategies for detecting and treating IBD in its early stages to prevent chronic disease progression.

Dr. Douglas Galasko's lab focuses on research related to Alzheimer's disease, a chronic condition that affects memory and cognition. The lab is currently developing a new drug, GSM-779690, which aims to prevent and slow progress of the disease, particularly in individuals at high genetic risk. This research includes conducting various safety and toxicology studies before advancing to clinical trials.

Dr. Jona A. Hattangadi-Gluth's lab focuses on understanding how radiation therapy affects cognitive function in patients with glioma, a type of brain tumor. The team conducts studies to identify the factors that influence cognitive decline after treatment and aims to develop interventions that can protect brain function during radiation therapy. They use advanced imaging techniques and cognitive assessments to explore the connections between brain injury and cognitive performance over time, with the ultimate goal of improving patient outcomes and addressing health disparities.

Dr. Gulcin Pekkurnaz's lab at UC San Diego studies how the brain's energy metabolism supports cognitive functions like memory and perception. The team focuses on specific brain cells called fast-spiking inhibitory interneurons, which require a lot of energy to help maintain brain rhythms crucial for cognitive tasks. By understanding how these neurons produce and regulate energy, they hope to uncover links between nutrition, brain function, and disorders like Alzheimer's disease.

Dr. Richard Daneman's lab investigates how blood vessels in the brain function, specifically in the context of Alzheimer's disease. They focus on a protein called SOX18, which appears to play a crucial role in maintaining the health of these blood vessels and preventing problems that may contribute to Alzheimer's. By studying both mouse models and human cell systems, the lab aims to understand the mechanisms behind blood vessel dysfunction in Alzheimer's and explore potential therapies targeting SOX18.

Dr. Shadi Dayeh's research lab at UC San Diego focuses on developing advanced technologies for monitoring and treating epilepsy. They aim to create high-resolution wireless microelectrodes that allow for a better understanding of brain activity during seizures. By building a system with thousands of channels, they intend to improve the diagnosis and treatment options for individuals with intractable epilepsy, ultimately enhancing patient care.

Dr. Ahmed El Kaffas's lab at UC San Diego focuses on developing innovative imaging technologies to better understand liver cancers. They use advanced 3D ultrasound techniques to create detailed maps of tumor blood vessels, which can help predict how well a patient is responding to treatments. Their research has the potential to improve diagnostics and support more personalized treatment plans for liver malignancies.

Adam Engler's lab focuses on understanding how mechanical properties at the cellular level affect the aging of heart muscle cells. By using innovative engineering techniques, the lab investigates how changes in cellular structures contribute to heart function over time, particularly looking at the connections between the nucleus and the heart's contractile components. This research aims to develop methods to restore function in aging hearts, potentially improving health and longevity.

Professor Sheng Zhong leads a lab at UC San Diego that focuses on understanding how cells make critical fate decisions during early embryonic development. Utilizing advanced techniques like fluorescence resonance energy transfer (FRET) biosensors, the lab investigates the dynamic changes in histone modifications and chromatin structures at single-cell levels. Their research aims to map out the complex epigenetic regulation that influences cell differentiation and gene expression, contributing to our understanding of developmental biology and regenerative medicine.

Dr. Carrie R. McDonald leads a research lab at UC San Diego focused on understanding the connection between epilepsy and brain aging in older adults. Her lab investigates how cognitive decline and Alzheimer's disease are linked to epilepsy, aiming to identify risk factors that can be modified to improve patient outcomes. Through advanced imaging and genetic studies, the research seeks to predict treatment responses in epilepsy and enhance patient care for older adults.

Dr. Jerry Yang's lab focuses on creating advanced fluorescent probes that help in detecting amyloid formations in the brain, which are linked to neurodegenerative diseases like Alzheimer's, Parkinson's, and Frontotemporal Dementia. The research aims to improve diagnostic tools that can identify various forms of amyloid in living patients, enhancing early detection and treatment options. By developing methods to study amyloid deposits, the lab contributes significantly to understanding and managing these debilitating conditions.

The research lab of Dr. James T. Kadonaga focuses on understanding how genes are regulated in humans, particularly the processes involving RNA polymerase II transcription. By exploring the core promoter regions and the proteins that interact with them, the lab aims to unravel the complexities of gene expression that can lead to diseases, including cancer. The research also investigates the biological roles of specific nucleosome-binding proteins to deepen our understanding of gene regulation.

Dr. Joseph Gleeson's lab at the University of California, San Diego is focused on understanding the genetic and environmental factors contributing to Meningomyelocele, a common congenital condition known as Spina Bifida. The lab aims to explore how genetic mutations interact with folic acid exposure during pregnancy to influence the risk of this condition. By studying families affected by Spina Bifida, the lab seeks to identify genetic markers that could lead to better prevention and treatment strategies for this serious birth defect.

Dr. Ananda W Goldrath's lab at UC San Diego focuses on understanding how T cells, especially memory CD8 T cells, adapt to different tissues in the body to provide effective immunity against infections and cancers. The lab investigates the unique changes in gene expression and metabolism that allow these immune cells to survive and function in various environments, particularly in the small intestine. This research has implications for developing better vaccines and immunotherapies tailored to enhance the immune response in specific tissues.

Dr. Steven L. Gonias's lab focuses on understanding the anti-inflammatory effects of a harmless form of prion protein in the brain, which could lead to new treatments for neurodegenerative diseases like Alzheimer's and Parkinson's. His research explores how this protein interacts with specific cellular receptors to reduce harmful inflammation in brain cells, particularly microglia and astrocytes. By studying these processes in mouse models, the lab aims to develop therapies that enhance the brain's natural defenses against inflammation.

Dr. Hector M Gonzalez's lab at UC San Diego focuses on understanding how neurocognitive aging and Alzheimer's disease affect the Latino population, which is projected to experience the highest increase in related cases. By examining cardiovascular disease and its impact on cognitive aging, the lab aims to fill critical gaps in knowledge that can inform public health strategies. The research combines advanced biomarkers, cognitive assessments, and genetic data to explore how these factors influence Alzheimer's disease risk and progression among diverse Latinos.

Dr. Jorge Silvio Gutkind's lab at UC San Diego focuses on improving treatments for head and neck cancer, a disease that currently has low survival rates and limited responses to conventional therapies. The lab is investigating how disruptions in certain cellular signaling pathways contribute to cancer progression and immune evasion. They are also exploring innovative approaches using chemokines to enhance the effectiveness of immunotherapies, aiming to make treatments more successful for patients.

Ryan E Hibbs' lab at UC San Diego focuses on understanding the structure and function of important neurotransmitter receptors that are linked to various diseases. Their research explores how nicotinic acetylcholine receptors and GABAA receptors operate in healthy conditions and how they are affected by autoimmune diseases and drug interactions. By using advanced techniques like cryo-electron microscopy and electrophysiology, the lab aims to uncover the fundamental mechanisms behind these receptors to improve treatments for disorders such as myasthenia gravis and epilepsy.

Dr. Thomas Hnasko's lab at UC San Diego focuses on understanding how specific neurons in the brain contribute to behaviors related to addiction, particularly with opioids. His research investigates novel neuron types in the ventral tegmental area (VTA) and their roles in drug reinforcement and withdrawal symptoms. By studying these neural circuits, the lab aims to identify new targets for therapeutic interventions in opioid use disorder and other addictions.

Dr. Vivian Y. H. Hook's lab at UC San Diego focuses on understanding the complex neuropeptide systems in the human brain, particularly how they are altered in Alzheimer’s disease. The research aims to identify specific neuropeptides and the enzymes that produce them, which can help explain synaptic dysfunction in Alzheimer’s. Insights from this work could lead to new biomarkers for Alzheimer's and potential therapeutic targets for treatment.